Product
Supplier
Encyclopedia
Inquiry
ODM-201 1297538-32-9 high purity 9% factory supply buy - large image1
ODM-201 1297538-32-9 high purity 9% factory supply buy - image1

ODM-201 1297538-32-9 high purity 9% factory supply

1 Inquiries

Unit Price: Get Latest Price
CAS No.:

1297538-32-9

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shanghai

Packaging:

100g/1kg/10kg

Price valid (until):

2025-09-28

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Semaglutide,Tirzepatide,Retatrutide,Pharmaceutical Peptide,Cosmetic peptide,Custom peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    ODM-201 is a novel androgen receptor (AR) inhibit designed to inhibit the growth of prostate cancer cells through binding to the AR to inhibit the testosterone-induced AR nuclear translocation. It is particularly used in patients with progressive metastatic castration-resistant prostate cancer. It is effective in inhibiting the activity of some mutant ARs emerging during antiandrogen therapies, including the F876L mutation version which is resistant to enzalutamide and ARN-509 (the second-generation antiandrogens).Therefore, it has potential to overcome the resistance issue occurring upon AR-targeted therapies.

    Basic Info
    Product Name:

    N-[(1S)-2-[3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl]-1-methylethyl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide

    CAS No.:

    1297538-32-9

    Molecular Formula:

    C19H19ClN6O2

    InChIKeys:

    InChIKey=BLIJXOOIHRSQRB-PXYINDEMSA-N

    Molecular Weight:

    398.846

    Exact Mass:

    398.85

    Characteristics
    PSA:

    119.62

    XLogP3:

    3.06098

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Semaglutide,Tirzepatide,Retatrutide,Pharmaceutical Peptide,Cosmetic peptide,Custom peptides

    Location:

    Room 204, Building 2, No. 398 Jinhuan Road, Jinshan District, Shanghai, China

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2014

    Our company is committed to providing high-quality, comprehensive peptide customization services and technical support for domestic and foreign biotechnology companies, research institutes and universities.
  • Inquiry History
    1 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Darolutamide

    100 G Aug 21, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.